Skip to content
Sign in

MRK · NYSE

Merck & Co. (MRK) Stock Price & Fundamentals

$1,376.99+0.57%+$7.75End-of-day price as of Oct 9, 2026

Merck & Co. (MRK) closed at $1,376.99 on Oct 9, 2026, up 0.57% from the previous close of $1,369.24.

Share price, past year

1Y +33.24%

52-week range $1,012.23 – $1,410.52. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$1,376.99
Sep 30, 2026$1,342.92
Aug 31, 2026$1,346.34
Jul 31, 2026$1,352.32
Jun 30, 2026$1,360.05
May 29, 2026$1,339.83
Apr 30, 2026$1,371.92
Mar 31, 2026$1,378.44
Feb 27, 2026$1,263.45
Jan 30, 2026$1,195.55
Dec 31, 2025$1,099.96
Nov 28, 2025$1,035.01
Oct 31, 2025$1,033.86

Key statistics

Market cap
$3.40T
P/E (TTM)
1,101.6
EPS (TTM)
$1.25
Revenue (TTM)
$66.57B
Net income (TTM)
$3.17B
Shares outstanding
2.5B
Dividend yield
0.24%
52-week range
$1,012.23 – $1,410.52

Merck & Co.'s market cap is $3.40T, based on a share price of $1,376.99 and 2.5B shares outstanding as of Jul 31, 2026.

Financials

Merck & Co. reported revenue of $65.01B for fiscal 2025, up 1.31% from fiscal 2024.

Merck & Co. earned net income of $18.25B in fiscal 2025, a net margin of 28.1%.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Merck & Co. annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$65.01B+1.3%$18.25B28.1%$7.28$12.36B
FY2024ended Dec 31, 2024$64.17B+6.7%$17.12B26.7%$6.74$18.10B
FY2023ended Dec 31, 2023$60.12B+1.4%$365.00M0.6%$0.14$9.14B
FY2022ended Dec 31, 2022$59.28B+21.7%$14.52B24.5%$5.71$14.71B
FY2021ended Dec 31, 2021$48.70B+17.3%$13.05B26.8%$5.14—
FY2020ended Dec 31, 2020$41.52B+6.1%$7.07B17.0%$2.78—
FY2019ended Dec 31, 2019$39.12B−7.5%$9.84B25.2%$3.81—
FY2018ended Dec 31, 2018$42.29B+5.4%$6.22B14.7%$2.32—
FY2017ended Dec 31, 2017$40.12B+0.8%$2.39B6.0%$0.87—
FY2016ended Dec 31, 2016$39.81B—$3.92B9.9%$1.41—
Merck & Co. quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$16.61B−$1.34B−$0.54
Q1 FY2026ended Mar 31, 2026$16.29B−$4.24B−$1.72
Q4 FY2025ended Dec 31, 2025$16.40B$2.96B$1.19
Q3 FY2025ended Sep 30, 2025$17.28B$5.79B$2.32
Q2 FY2025ended Jun 30, 2025$15.81B$4.43B$1.76
Q1 FY2025ended Mar 31, 2025$15.53B$5.08B$2.01
Q4 FY2024ended Dec 31, 2024$15.62B$3.74B$1.49
Q3 FY2024ended Sep 30, 2024$16.66B$3.16B$1.24

Company profile

Name
Merck & Co., Inc.
Ticker
MRK
Exchange
NYSE
Industry (SEC SIC)
Pharmaceutical Preparations
Headquarters
126 East Lincoln Avenue, P.O. Box 2000, Rahway, NJ 07065
Incorporated in
NJ
Fiscal year ends
December
SEC CIK
0000310158

Recent SEC filings

Frequently asked questions

What is Merck & Co.'s stock price?

Merck & Co. (MRK) closed at $1,376.99 on Oct 9, 2026, up 0.57% from the previous close of $1,369.24.

What is Merck & Co.'s market cap?

Merck & Co.'s market cap is $3.40T, based on a share price of $1,376.99 and 2.5B shares outstanding as of Jul 31, 2026.

How much revenue does Merck & Co. make?

Merck & Co. reported revenue of $65.01B for fiscal 2025, up 1.31% from fiscal 2024.

What is MRK's P/E ratio?

Merck & Co.'s price-to-earnings ratio is 1,101.6, based on trailing twelve-month diluted EPS of $1.25.

Does Merck & Co. pay a dividend?

Yes. Merck & Co. declared $3.36 per share in dividends over the last four quarters, a yield of 0.24%.

Sources and methodology

Fundamentals come from Merck & Co., Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures